<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS206962</article-id><article-id pub-id-type="doi">10.1101/2025.06.16.659870</article-id><article-id pub-id-type="archive">PPR1037539</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Bacteriophage diversity declines with COPD severity in the respiratory microbiome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Ryan A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ponsero</surname><given-names>Alise J.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Telatin</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yuqiong</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Zhenyu</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Fengyan</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Rongchang</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Adriaenssens</surname><given-names>Evelien M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Clokie</surname><given-names>Martha RJ.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Millard</surname><given-names>Andrew D.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Brightling</surname><given-names>Christopher E.</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib></contrib-group><aff id="A1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04td3ys19</institution-id><institution>Quadram Institute Bioscience</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0062dz060</institution-id><institution>Norwich Research Park</institution></institution-wrap>, <city>Norwich</city>, <country country="GB">United Kingdom</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00z0j0d77</institution-id><institution>First Affiliated Hospital of Guangzhou Medical University</institution></institution-wrap>, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, State Key</aff><aff id="A3"><label>3</label>Institute of Ecological Sciences, School of Life Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kq0pv72</institution-id><institution>South China Normal University</institution></institution-wrap>, <city>Guangdong</city>, <country country="CN">China</country></aff><aff id="A4"><label>4</label>Becky Mayer Centre for Phage Research, Department of Genetics and Genome Biology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h699437</institution-id><institution>University of Leicester</institution></institution-wrap>, <city>Leicester</city>, <country country="GB">United Kingdom</country></aff><aff id="A5"><label>5</label>Institute for Lung Health, National Institute for Health and Care Research, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05xqxa525</institution-id><institution>Leicester Biomedical Research Centre</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h699437</institution-id><institution>University of Leicester</institution></institution-wrap>, <city>Leicester</city>, <country country="GB">United Kingdom</country></aff><author-notes><corresp id="CR1">
<label>*</label>Denotes corresponding author; <email>Ryan.Cook@quadram.ac.uk</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>11</day><month>07</month><year>2025</year></pub-date><pub-date pub-type="preprint"><day>16</day><month>06</month><year>2025</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Chronic obstructive pulmonary disease (COPD) severity correlates with airway microbial dysbiosis, yet bacteriophage roles remain unexplored. We characterised the lung virome by re-analysing 135 sputum metagenomes from 99 COPD patients and 36 healthy controls. We identified 1,308 viral operational taxonomic units, revealing progressively lower viral diversity correlating with disease severity. Whilst viral and bacterial diversity typically showed strong positive correlations, patients with frequent exacerbations uniquely exhibited decoupled viral-bacterial relationships, indicating disrupted ecological dynamics. Phages infecting anaerobic oral bacteria showed disproportionately lower abundance—<italic>Porphyromonas</italic> phages were 40-fold less abundant despite only 4-fold lower bacterial abundance—whilst pathogen-associated phages showed no significant differences. We detected virulence factor-encoding phages, including two <italic>neuA</italic>-carrying <italic>Haemophilus</italic> phages in 7.4% of <italic>Haemophilus</italic>-colonised patients, associated with 82-fold higher bacterial abundance. These findings establish altered bacteriophage ecology as an unrecognised feature of COPD pathobiology, with differential phage-bacteria relationships that reshape lung microbial ecosystems, offering new perspectives for microbiome-targeted interventions.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Background</title><p id="P2">Chronic obstructive pulmonary disease (COPD) ranks among the leading causes of mortality worldwide, responsible for over three million deaths annually<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. This heterogeneous disease encompasses emphysema and chronic bronchitis, with patients experiencing varied clinical trajectories. Disease severity is assessed through the Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging system, grading airflow limitation from mild (GOLD 1) to very severe (GOLD 4)<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. However, recognising that airflow limitation alone inadequately predicts clinical outcomes, the ABE assessment tool stratifies patients by symptom burden and exacerbation history—Group A (low symptoms/low exacerbations), Group B (high symptoms/low exacerbations), and Group E (frequent exacerbations)<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. This emphasis on exacerbation frequency reflects its critical role as an independent predictor of mortality and disease progression. Beyond clinical classifications, COPD manifests distinct inflammatory endotypes influencing treatment responses. Neutrophilic inflammation (elevated sputum neutrophils) associates with bacterial colonisation and poor corticosteroid response, whilst eosinophilic inflammation (elevated sputum eosinophils) predicts better corticosteroid outcomes<sup><xref ref-type="bibr" rid="R3">3</xref></sup>.</p><p id="P3">The bacterial component of the lung microbiome plays a well-established role in COPD pathogenesis, with dysbiosis linked to disease progression, exacerbations, and therapeutic responses<sup><xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R6">6</xref></sup>. However, the viral component remains unexplored beyond eukaryotic respiratory viruses in acute exacerbations<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. This oversight is striking given bacteriophages’ profound influence on microbial communities across all ecosystems<sup><xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref></sup>.</p><p id="P4">Bacteriophages shape bacterial communities through diverse mechanisms beyond predation. Lytic phages kill hosts without integration into the host genome, regulating populations through “Kill-the-Winner” dynamics<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Temperate phages integrate as prophages into the host genome, often carrying virulence factors that can transform benign bacteria into pathogens<sup><xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref></sup>. Environmental stresses—including antibiotics, inflammation, or nutrient limitation—can trigger prophage induction, reshaping microbial communities<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup>.</p><p id="P5">In cystic fibrosis, which shares pathophysiological features with COPD, bacteriophages directly impact clinical outcomes. Filamentous phages impair mucociliary clearance, promote antibiotic resistance, and correlate with worse prognosis<sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>, suggesting phages may similarly influence COPD pathogenesis.</p><p id="P6">The recent publication of comprehensive COPD metagenomes by Yan et al.<sup><xref ref-type="bibr" rid="R18">18</xref></sup> revealed airway microbiome alterations associated with neutrophilic inflammation and identified microbial metabolites linked to disease severity. However, the previous analysis focused on bacteria, leaving viral components unexamined. Here, we applied state-of-the-art bioinformatic approaches to study the DNA virome of these data, revealing alterations in viral ecology associated with COPD. We demonstrate progressive viral diversity loss correlating with disease severity, identify decoupled viral-bacterial relationships in frequent exacerbators (Group E), and detect virulence-encoding phages associated with dramatically elevated pathogen abundance. These findings establish the virome as a previously unrecognised component of COPD pathobiology with implications for understanding disease mechanisms and developing novel therapeutics.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Study Cohort and Viral Catalogue Overview</title><p id="P7">We re-analysed 135 sputum metagenomes from 99 COPD patients and 36 healthy controls originally published by Yan et al. The cohort spanned the clinical spectrum of COPD: GOLD stages 1-4 (n=21, 40, 29, and 9 respectively, <xref ref-type="fig" rid="F1">Figure 1A</xref>), ABE groups A (n=48, low symptoms/low exacerbations), B (n=29, high symptoms/low exacerbations), and E (n=20, high exacerbations) (<xref ref-type="fig" rid="F1">Figure 1B</xref>), and inflammatory endotypes including neutrophilic (n=31), eosinophilic (n=11), mixed granulocytic (n=50), and paucigranulocytic (n=5) (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Two patients lacked metadata for classification.</p><p id="P8">Viral mining yielded 1,308 viral operational taxonomic units (vOTUs; approximate to species, <xref ref-type="fig" rid="F1">Figure 1D</xref>), ranging from 1.1-252.2 kb (median 14.1 kb, <xref ref-type="fig" rid="F1">Figure 1E</xref>). Quality assessment classified 108 vOTUs as complete, 161 as high-quality (&gt;90% predicted complete), and 340 as medium-quality (&gt;50% predicted complete) (<xref ref-type="fig" rid="F1">Figure 1G</xref>). The majority (79.3%) represented novel viral diversity, with only 271 vOTUs assignable to known families, though 892 (68.2%) could be classified as <italic>Caudoviricetes</italic> (tailed phages). Lifestyle predictions indicated 688 obligately lytic and 370 temperate viruses (<xref ref-type="fig" rid="F1">Figure 1F</xref>), whilst host predictions linked 675 vOTUs to 88 bacterial genera, most commonly <italic>Prevotella</italic> (n=81), <italic>Pauljensenia</italic> (n=68), and <italic>Streptococcus</italic> (n=60) (<xref ref-type="fig" rid="F1">Figure 1H</xref>).</p></sec><sec id="S4"><title>Progressive Viral Diversity Loss Correlates with COPD Severity</title><p id="P9">Viral alpha diversity declined significantly with disease severity across multiple clinical classifications. Shannon diversity showed progressive reduction from healthy controls (1.93 ± 1.27) through GOLD stages 1-2 (1.27 ± 1.08 and 1.33 ± 1.16) to stages 3-4 (0.83 ± 0.97 and 0.69 ± 0.89; Kruskal-Wallis χ<sup>2</sup> = 16.99, p = 0.002). Post-hoc analyses confirmed significant reductions in GOLD 3 (p = 0.001) and GOLD 4 (p = 0.010) compared to controls, suggesting a threshold effect where viral community disruption becomes pronounced in severe disease (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The substantial within-group variation was notable, with some patients harbouring no detectable vOTUs in their metagenomes despite adequate sequencing depth, highlighting the heterogeneous nature of viral depletion in COPD.</p><p id="P10">All ABE groups showed reduced viral diversity compared to controls (Kruskal-Wallis χ<sup>2</sup> = 13.47, p = 0.009): Group A (1.23 ± 1.24, p = 0.019), Group B (1.10 ± 0.89, p = 0.018), and Group E (0.94 ± 0.96, p = 0.022). However, no differences existed between ABE groups (all pairwise p &gt; 0.05), indicating viral depletion occurs independently of symptom burden or exacerbation frequency (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Community evenness (Inverse Simpson diversity) showed a trend toward lower values in Group E (p = 0.051), suggesting their viral communities may be dominated by fewer abundant species.</p><p id="P11">Inflammatory endotypes also showed significant differences in viral diversity (Kruskal-Wallis χ<sup>2</sup> = 15.45, p = 0.009). Patients with eosinophilic inflammation showed the most pronounced reduction in viral diversity (0.82 ± 1.17 vs 1.93 ± 1.27 in controls, p = 0.017, <xref ref-type="fig" rid="F2">Figure 2C</xref>). Viral diversity negatively correlated with sputum eosinophil counts (Spearman’s ρ = -0.257, p = 0.003), as did bacterial diversity (ρ = -0.232, p = 0.007).</p><p id="P12">However, mediation analysis revealed these relationships are interdependent, with 61% of the eosinophil-viral association mediated through bacterial diversity (p = 0.028), suggesting type 2 inflammation may drive coordinated suppression of both microbial domains.</p><p id="P13">Analysis of predicted viral lifestyle revealed additional endotype-specific patterns. Whilst temperate virus relative abundance remained constant across all disease classifications, obligately lytic virus proportions differed significantly by inflammatory endotype (Kruskal-Wallis χ<sup>2</sup> = 13.70, p = 0.018). Patients with a paucigranulocytic endotype showed dramatically elevated obligately lytic virus abundance (72.4% ± 17.4%) compared to all other groups: healthy controls (30.2% ± 24.2%, p = 0.004), eosinophilic (16.6% ± 15.8%, p = 0.016), mixed granulocytic (25.4% ± 25.1%, p = 0.006), and neutrophilic inflammation (24.7% ± 28.6%, p = 0.004). This 3-fold increase in obligately lytic viruses correlated strongly with overall viral community metrics (Shannon diversity: ρ = 0.671, p &lt; 0.001; total viral load: ρ = 0.436, p &lt; 0.001), suggesting that lytic viral activity may drive viral community richness in low-inflammation environments.</p><p id="P14">Viral load (percentage of total reads mapping to viral contigs) correlated positively with all viral diversity metrics (Shannon: ρ = 0.45, p &lt; 0.001; richness: ρ = 0.52, p &lt; 0.001; Inverse Simpson: ρ = 0.31, p &lt; 0.001). Patients with high viral loads (&gt;75th percentile, &gt;2.1%) maintained significantly greater diversity than those with low loads (&lt;25th percentile, &lt;0.6%) across all metrics (Wilcoxon test, all p &lt; 0.001), with high-load patients averaging 10-fold higher richness (41.1 ± 57.7 vs 4.1 ± 4.8 vOTUs).</p></sec><sec id="S5"><title>Disrupted Viral-Bacterial Ecological Relationships in Frequent Exacerbators</title><p id="P15">Viral and bacterial diversity typically showed strong positive correlations (richness: ρ = 0.704, p &lt; 0.0001; Shannon: ρ = 0.502, p &lt; 0.0001), with both communities declining in parallel with disease severity (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Healthy controls maintained the highest bacterial diversity (Shannon: 2.98 ± 0.81, 86.5 ± 63.8 genera), with all COPD groups showing significant reductions (all p &lt; 0.001).</p><p id="P16">However, this coordinated relationship uniquely broke down in patients with frequent exacerbations (Group E), for which the correlation between viral and bacterial diversity disappeared (ρ = 0.052, p = 0.833), contrasting sharply with maintained correlations in Groups A (ρ = 0.643, p &lt; 0.005) and B (ρ = 0.511, p &lt; 0.005). Partial correlation analysis controlling for GOLD stage and inflammatory endotype confirmed this pattern: Groups A and B retained significant correlations (partial ρ = 0.676 and 0.442, respectively; both p &lt; 0.05), whilst Group E remained uncorrelated (partial ρ = -0.198, p = 0.447). This decoupling in frequent exacerbators represents a distinct ecological disruption independent of disease severity or inflammatory status.</p><p id="P17">The decoupling was specific to the ABE classification. When stratified by GOLD stage, all groups except GOLD 4 (likely due to small sample size, n=8) maintained significant viral-bacterial correlations (GOLD 1: ρ = 0.542, p = 0.011; GOLD 2: ρ = 0.378, p = 0.016; GOLD 3: ρ = 0.452, p = 0.014). Similarly, all inflammatory endotypes preserved the relationship: neutrophilic (ρ = 0.507, p = 0.0036), mixed granulocytic (ρ = 0.443, p = 0.0014), and eosinophilic (ρ = 0.442, though p = 0.174 due to small sample size, n=11).</p></sec><sec id="S6"><title>Limited Viral Community Structuring Despite Diversity Loss</title><p id="P18">Beta diversity analysis using Bray-Curtis dissimilarity revealed subtle but significant viral community structuring by clinical phenotypes. ABE classification explained 4.5% of community variation (PERMANOVA R<sup>2</sup> = 0.045, p = 0.02, <xref ref-type="fig" rid="F3">Figure 3A</xref>), with Group B (high symptoms, low exacerbations) harbouring the most distinct viral communities, differing significantly from healthy controls (R<sup>2</sup> = 0.051, adjusted p = 0.020) and Group A (R<sup>2</sup> = 0.032, adjusted p = 0.023). Surprisingly, neither Group A nor E differed from controls (p = 0.610 and 0.706, respectively), and Groups A and E were virtually indistinguishable (R<sup>2</sup> = 0.008, p = 0.974).</p><p id="P19">Overall COPD status did not create a distinct viral signature at the vOTU level (R<sup>2</sup> = 0.011, p = 0.132), though clinical subgroups within COPD showed significant differentiation (R<sup>2</sup> = 0.047, p = 0.036). Significant heterogeneity in multivariate dispersion (PERMDISP: ABE groups F = 5.19, p = 0.002; endotypes F = 3.77, p = 0.003, <xref ref-type="fig" rid="F3">Figure 3C</xref>) indicated some groups harbour more variable viral communities, potentially reflecting different stages of ecological stability. Neither GOLD classification (R<sup>2</sup> = 0.042, p = 0.055, <xref ref-type="fig" rid="F3">Figure 3B</xref>) nor inflammatory endotypes (R<sup>2</sup> = 0.050, p = 0.056) showed significant effects.</p><p id="P20">In contrast, bacterial communities showed stronger clinical structuring: ABE groups (R<sup>2</sup> = 0.067, p = 0.005), GOLD stages (R<sup>2</sup> = 0.066, p = 0.004), inflammatory endotypes (R<sup>2</sup> = 0.082, p = 0.003), and COPD vs healthy status (R<sup>2</sup> = 0.041, p = 0.003) all showed significant associations. Both communities experienced diversity loss, but only bacterial communities maintained clear associations with clinical phenotypes.</p><p id="P21">Although viral communities showed weak clinical structuring, they correlated significantly with bacterial community composition (Mantel r = 0.271, p = 0.001). This relationship persisted after controlling for disease status (r = 0.276, p = 0.001) or GOLD stage (r = 0.270, p = 0.001). Procrustes analysis confirmed significant congruence between viral and bacterial ordinations (correlation = 0.383, p = 0.001), with communities sharing approximately 15% of compositional variation despite their divergent clinical associations (correlation<sup>2</sup> = 0.147). Environmental fitting identified patient-reported symptom burden (CAT score) as the only clinical variable significantly associated with viral structure (r<sup>2</sup> = 0.108, p = 0.003), whilst objective measures including FEV1, BMI, and inflammatory markers showed no significant associations.</p></sec><sec id="S7"><title>Selective Depletion of Commensal-Associated Phages</title><p id="P22">Analysis of host-specific viral abundances revealed unexpected patterns. The key COPD pathogenic genera—<italic>Streptococcus</italic> (4.4% mean relative abundance, 68.1% prevalence), <italic>Haemophilus</italic> (3.4%, 50.4%), and <italic>Moraxella</italic> (2.0%, 11.1%, significantly elevated in COPD, p = 0.014)—were predicted as hosts for 90 vOTUs total. However, viruses infecting these classic COPD associated pathogens showed no significant differential abundance between groups after multiple testing correction.</p><p id="P23">Instead, consistent depletion occurred for viruses infecting oral and anaerobic genera (<xref ref-type="fig" rid="F4">Figure 4A</xref>). <italic>Porphyromonas</italic> viruses showed the strongest association (Kruskal-Wallis χ<sup>2</sup> = 25.4-26.9, p &lt; 0.001 across all comparisons), with 40-fold reduction in COPD (mean 25,792 vs 636 CPM) and prevalence dropping from 36.1% to 4.0%. Crucially, this viral depletion exceeded bacterial depletion—<italic>Porphyromonas</italic> bacterial abundance decreased only 4-fold (8.49% to 1.93%), suggesting virus-specific loss beyond host availability (<xref ref-type="fig" rid="F4">Figure 4B</xref>).</p><p id="P24">Similar disproportionate patterns occurred for <italic>Alloprevotella</italic> viruses (3-fold reduction despite only 1.2-fold bacterial change), <italic>Mogibacterium</italic> viruses (3.9-fold reduction vs 2.5-fold bacterial depletion), and <italic>Lancefieldella</italic> viruses. Of the differentially abundant host-grouped viruses, only <italic>Prevotella</italic> showed proportional changes (1.4-fold viral reduction, 1.7-fold bacterial reduction). These depletion patterns followed disease severity gradients, with progressive loss across GOLD stages and ABE classifications, suggesting selective disruption of virus-bacteria relationships for commensal organisms.</p><p id="P25">Virus-host ratio (VHR) analysis, calculated by dividing viral abundance by corresponding bacterial host abundance, encompassed 3,619 observations across 45 host genera. The strong negative correlation between VHR and bacterial abundance (overall ρ = -0.796, p &lt; 0.001, <xref ref-type="fig" rid="F4">Figure 4C</xref>) aligns with “Kill-the-Winner” ecological dynamics, where viral predation preferentially targets abundant bacterial populations. This pattern persisted across all clinical classifications: ABE groups (ρ = -0.816 to -0.663, all p &lt; 0.001), GOLD stages including controls (ρ = -0.591 to -0.853, all p &lt; 0.01), and inflammatory endotypes (ρ = -0.701 to -0.906, all p &lt; 0.05). The strongest correlations occurred in patients with eosinophilic inflammation (ρ = -0.892) and early disease (GOLD 1: ρ = -0.853), whilst the weakest appeared in severe disease (GOLD 4: ρ = -0.591), suggesting altered ecological dynamics in late-stage disease.</p></sec><sec id="S8"><title>Acute Viral Events: Eukaryotic Infections and Bacteriophage Blooms</title><p id="P26">Five patients exhibited extreme viral loads (&gt;10% metagenomic reads mapping to vOTUs), revealing distinct acute phenomena beyond the chronic viral depletion patterns (<xref ref-type="fig" rid="F5">Figure 5A-B</xref>). Two harboured active eukaryotic viral infections: Human mastadenovirus B (patient K171, 47.8% viral load, 78.1% relative abundance, <xref ref-type="fig" rid="F5">Figure 5E</xref>), a known respiratory pathogen, and a novel picorna-like virus most similar to a swan-associated virus (patient K170, 16.1% viral load, 91.0% relative abundance, <xref ref-type="fig" rid="F5">figure 5F</xref>). As picornaviruses are RNA viruses, detection in a DNA metagenome likely resulted from reverse transcription activity during amplification prior to sequence library preparation.</p><p id="P27">Two others showed “phage blooms”—dominance by single bacteriophages (<xref ref-type="fig" rid="F5">Figure 5C-D</xref>). Patient K110 (17.7% viral load) was dominated by a ˜52 kb lytic phage (95.5% relative abundance) with CRISPR spacer matches to <italic>Pauljensenia</italic>, whilst patient J048 (31.2% viral load) contained a dominant ˜80 kb temperate phage of unknown host (83.1% relative abundance). Both belonged to class <italic>Caudoviricetes</italic> but lacked family-level classification. These blooms resulted in extremely low diversity (five and three vOTUs respectively, Shannon = 0.23 and 0.48), suggesting periodic viral population collapses and expansions that may reflect prophage induction events or lytic phage amplification during bacterial blooms.</p></sec><sec id="S9"><title>Virulence-Associated Phages Show Strong Host Coupling</title><p id="P28">Screening against the Virulence Factor Database identified four vOTUs carrying bacterial virulence genes, targeting <italic>Haemophilus</italic> (n=2), <italic>Streptococcus</italic> (n=1), and <italic>Escherichia</italic> (n=1). The virulence factors included <italic>neuA</italic> (N-acylneuraminate cytidylyltransferase, involved in lipooligosaccharide biosynthesis and immune evasion)<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, <italic>lytA</italic> (autolysin, contributing to pneumococcal pathogenesis)<sup><xref ref-type="bibr" rid="R20">20</xref></sup>, and genes for lipopolysaccharide modification (<italic>gtrA, gtrB</italic>) that can alter bacterial surface antigens<sup><xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref></sup>. All four vOTUs were predicted to be temperate and may therefore be able to integrate into their hosts as prophages.</p><p id="P29">Most notably, two <italic>Haemophilus</italic>-targeting vOTUs carrying <italic>neuA</italic> were detected in 5 of 68 <italic>Haemophilus</italic>-positive samples (7.4%) (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Amongst <italic>Haemophilus</italic>-colonised patients, those harbouring either virulence-factor carrying phage showed dramatically elevated bacterial abundance compared to those without (median 37.3% vs 0.46%, 82-fold increase; mean 45.3% vs 3.7%, 12-fold increase; Wilcoxon test p = 5.5×10<sup>−4</sup>). This association was significant in COPD patients (4 of 46 colonised patients, p = 8.7×10<sup>−4</sup>), with only one instance detected in a healthy control (<xref ref-type="fig" rid="F6">Figure 6B</xref>).</p><p id="P30">These virulence-factor-encoding vOTUs appeared across different clinical groups (three Group A, one Group B, one healthy control). The strong ecological coupling suggests either phage-mediated enhancement of bacterial fitness through virulence factor provision, or preferential phage replication in high-density bacterial populations. However, the low prevalence limits broader conclusions about their role in COPD pathogenesis.</p></sec></sec><sec id="S10" sec-type="discussion"><title>Discussion</title><p id="P31">This re-analysis of the Yan et al. COPD metagenome dataset<sup><xref ref-type="bibr" rid="R18">18</xref></sup> reveals fundamental alterations in viral ecology that parallel and potentially contribute to disease progression. By applying specific virome-focused bioinformatic approaches to bulk metagenomes, we demonstrate that bacteriophage diversity loss represents a previously unrecognised feature of COPD correlating with disease severity and varying by inflammatory phenotype.</p><p id="P32">The progressive viral diversity decline from healthy controls through increasing COPD severity suggests viral community disruption may be integral to pathogenesis. This mirrors observations in inflammatory bowel disease and HIV infection, where reduced virome diversity correlates with disease activity<sup><xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref></sup>. The threshold effect—significant viral depletion manifesting primarily in GOLD stages 3-4—aligns with COPD as a disease of accumulated insults eventually overwhelming homeostatic mechanisms. Complete absence of detectable DNA viruses in some patients’ bulk metagenomes suggests profound ecological collapse, though this heterogeneity likely reflects varying disease trajectories, therapeutic histories, or sampling limitations.</p><p id="P33">Our finding that frequent exacerbators (Group E) uniquely exhibit decoupled viral-bacterial diversity relationships provides novel insight into this high-risk phenotype. Whilst viral and bacterial communities typically show coordinated responses, the absence of correlation in Group E suggests fundamentally altered microbial ecology. This may result from repeated antibiotic exposure during exacerbations, creating asynchronous selective pressures, or from the inflammatory milieu—characterised by neutrophil influx and oxidative stress—differentially affecting phage and bacterial survival. These findings have therapeutic implications: microbiome-targeted interventions in frequent exacerbators may need to consider viral communities independently from bacterial hosts.</p><p id="P34">The disproportionately lower abundance of phages targeting oral and anaerobic bacteria compared to their bacterial hosts adds complexity to understanding COPD dysbiosis. The 40-fold lower abundance of <italic>Porphyromonas</italic> phages despite only 4-fold lower bacterial abundance suggests factors beyond simple host availability. This could represent completed Kill-the-Winner cycles leaving resistant bacterial subpopulations, direct inflammatory effects on phage stability, or altered bacterial physiology reducing phage susceptibility. These differential patterns—lower abundance of phages targeting health-associated bacteria but unchanged pathogen-associated phages—could fundamentally alter community dynamics by removing phage-mediated control that normally limits pathogen expansion.</p><p id="P35">Persistent Kill-the-Winner dynamics across all COPD phenotypes, albeit with varying intensity, indicates fundamental ecological principles remain operative even in disrupted communities. The weakening of Kill-the-Winner dynamics in severe disease (GOLD 4) suggests deteriorating ecological regulation as communities simplify, with important implications for potential phage therapy approaches that must account for altered predator-prey dynamics and potentially reduced efficacy in advanced disease.</p><p id="P36">The acute viral events—both eukaryotic infections and bacteriophage blooms—observed in five patients warrant consideration. The phage blooms, characterised by single bacteriophages dominating the viral community (&gt;80% relative abundance), likely represent prophage induction events or rapid lytic amplification during bacterial population expansions. These extreme viral loads coincided with markedly reduced diversity, suggesting periodic boom-bust cycles that may contribute to the overall viral community instability observed in COPD.</p><p id="P37">Detection of virulence factor-encoding phages, particularly the <italic>neuA</italic>-carrying <italic>Haemophilus</italic> phages associated with dramatically elevated bacterial abundance, provides direct evidence of phage-mediated virulence enhancement in COPD lungs. To our knowledge, this represents the first demonstration of virulence factor-encoding bacteriophages in the human respiratory tract, paralleling the paradigm established by <italic>Vibrio cholerae</italic>, where prophage-encoded cholera toxin transforms an otherwise harmless bacteria into a pathogen<sup><xref ref-type="bibr" rid="R12">12</xref></sup>.</p><p id="P38">Several limitations merit consideration. The cross-sectional design prevents causal inference about whether viral depletion drives or results from disease progression, and precludes assessment of how treatments—particularly antibiotics and corticosteroids—shape viral-bacterial dynamics over time. Analysis of bulk metagenomes rather than dedicated viromes likely underestimates viral diversity, particularly for low-abundance phages<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. However, this approach captures both integrated prophages and free viruses, providing insight into temperate phage populations that may contribute to bacterial metabolism<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. Our focus on DNA viruses excludes RNA viruses, established contributors to COPD exacerbations<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. Additionally, whilst sputum sampling captures clinically relevant communities, it may not fully represent lower airway ecology. Small sample sizes for some inflammatory endotypes, particularly paucigranulocytic, limit generalisability for these groups.</p><p id="P39">Future research should establish temporal relationships between viral depletion and disease progression through longitudinal studies. Incorporating metatranscriptomics would reveal whether detected prophages are actively expressed, providing crucial insight into lysogenic-lytic switches and real-time phage-bacteria interactions that shape disease progression. Dedicated virome sequencing, including RNA viruses, would provide comprehensive viral characterisation. Investigation of common COPD therapeutics’ effects on viral communities could inform treatment strategies, whilst mechanistic studies examining how specific medications—particularly inhaled corticosteroids and antibiotics—shape viral ecology could guide targeted approaches. Exploring functional consequences of viral alterations, including effects on bacterial virulence, antibiotic resistance, and host immunity, could reveal novel therapeutic targets.</p><p id="P40">In conclusion, this analysis establishes alterations in bacteriophage ecology as a previously unrecognised feature of COPD pathobiology. Progressive viral diversity loss, disrupted viral-bacterial relationships in frequent exacerbators, and selective depletion of commensal-associated phages represent fundamental changes in lung microbial ecology likely contributing to disease progression. These findings highlight the importance of considering viral communities alongside bacteria in understanding respiratory dysbiosis and suggest comprehensive microbiome-targeted therapies should account for the viral component of the lung ecosystem.</p></sec><sec id="S11" sec-type="methods"><title>Methods</title><sec id="S12"><title>Read QC and Assembly</title><p id="P41">Paired end fastq files were processed using fastp v0.24.0 with --detect_adapter_for_pe and -q 30<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. Human reads had already been removed in the original analysis by mapping to human genome GRCh38 using BWA v.0.7.17<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R29">29</xref></sup>. Library sizes were calculated using the count command within SeqFu v1.22.3<sup><xref ref-type="bibr" rid="R30">30</xref></sup>. Samples were individually assembled using metaSPAdes v4.0.0 with default parameters<sup><xref ref-type="bibr" rid="R31">31</xref></sup>. Assembly graphs were used as input for Phables v1.4.1 using default parameters<sup><xref ref-type="bibr" rid="R32">32</xref></sup>, that is known to increase the recovery of complete viral genomes from human samples<sup><xref ref-type="bibr" rid="R33">33</xref></sup>.</p></sec><sec id="S13"><title>Viral Mining</title><p id="P42">Viral contigs were predicted using geNomad v1.8.1<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. Predicted viruses were processed using CheckV v1.0.3 end_to_end <sup><xref ref-type="bibr" rid="R35">35</xref></sup>. Putative viruses with complete ≥ 50% (equivalent to CheckV “Medium-quality) or length ≥ 10Kb were retained and de-replicated to form viral operational taxonomic units (vOTUs) following Minimum Information about an Uncultivated Virus Genome (MIUViG) standards (95% ANI over 85% length) using blast v2.14.0+ alongside the anicalc.py and aniclust.py scripts described in the CheckV documentation (<ext-link ext-link-type="uri" xlink:href="https://bitbucket.org/berkeleylab/checkv/src/master/">https://bitbucket.org/berkeleylab/checkv/src/master/</ext-link>)<sup><xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R37">37</xref></sup>.</p></sec><sec id="S14"><title>vOTU Annotation</title><p id="P43">Functional annotation of vOTUs was performed using Pharokka v1.7.4 with -g prodigal-gv that uses tRNAscan-SE 2.0, Aragorn, CRT, PHROGs, VFDB, CARD, MMseqs2, PyHMMER, INPHARED and MASH<sup><xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R49">49</xref></sup>. Subsequent annotation was performed using PHOLD v0.2.0 (<ext-link ext-link-type="uri" xlink:href="https://github.com/gbouras13/phold">https://github.com/gbouras13/phold</ext-link>) that implements Foldseek and ProstT5<sup><xref ref-type="bibr" rid="R50">50</xref>,<xref ref-type="bibr" rid="R51">51</xref></sup>. Host prediction was performed using iPHoP v1.3.3<sup><xref ref-type="bibr" rid="R52">52</xref>–<xref ref-type="bibr" rid="R56">56</xref></sup> and lifestyle was predicted using PhaTYP<sup><xref ref-type="bibr" rid="R57">57</xref></sup>. Family-level taxonomic assignments were extracted from geNomad and further taxonomic assignments were made using taxMyPhage v03.3<sup><xref ref-type="bibr" rid="R58">58</xref></sup>.</p></sec><sec id="S15"><title>Community Profiling</title><p id="P44">Reads were mapped to vOTUs using bowtie2 v2.5.4 with --non-deterministic and -- maxins 2000 with output piped to samtools v1.21 to produce a sorted bam file for each sample<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref></sup>. Abundance was calculated as CPM (analogous to the RNA-Seq measure of TPM) using CoverM contig v0.7.0 with --min-read-aligned-percent 90 and --min-covered-fraction 0.75<sup><xref ref-type="bibr" rid="R61">61</xref></sup>. Bacterial community composition was assessed using MetaPhlAn v4.1.1 with bowtie2 v2.5.4, -t rel_ab, -x mpa_vJun23_CHOCOPhlAnSGB_202307, -- ignore_eukaryotes, and --unclassified_estimation<sup><xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R62">62</xref></sup>. Diversity indices for bacteria were calculated using the genus level predictions and for viruses using CPM of vOTUs.</p></sec><sec id="S16"><title>Statistical Analysis</title><p id="P45">All statistical analyses were performed in R (v4.2.1) using the vegan package (v2.6-4) for ecological analyses. Alpha diversity metrics (Shannon diversity, Inverse Simpson, and observed richness) were calculated for both viral and bacterial communities. Due to non-normal data distributions and unequal sample sizes, non-parametric tests were employed throughout. Differences in diversity metrics across clinical groups (ABE classification, GOLD stages, and inflammatory endotypes) were assessed using Kruskal-Wallis tests, followed by Dunn’s post-hoc tests with Benjamini-Hochberg correction for multiple comparisons. Direct comparisons between two groups used Wilcoxon rank-sum tests. Correlations between continuous variables (viral diversity, bacterial diversity, eosinophil counts, viral load) were evaluated using Spearman’s rank correlation coefficient.</p><p id="P46">Beta diversity analysis was performed on viral abundance matrices using Bray-Curtis dissimilarity. Community structure differences between clinical groups were tested using permutational multivariate analysis of variance (PERMANOVA; adonis2 function, 999 permutations). To assess whether significant PERMANOVA results reflected true location differences or dispersion effects, we tested for homogeneity of multivariate dispersions using PERMDISP (betadisper and permutest functions, 999 permutations). Nested PERMANOVA was employed to first test overall COPD versus healthy differences, followed by within-COPD group comparisons. Pairwise PERMANOVA comparisons between groups were conducted with Benjamini-Hochberg correction for multiple testing.</p><p id="P47">To examine viral-bacterial community relationships, Mantel tests (999 permutations) were performed between Bray-Curtis dissimilarity matrices calculated from viral and bacterial abundance data. Partial Mantel tests controlled for potential confounders including disease status and GOLD stage. Procrustes analysis provided an independent assessment of community correlation through superimposition of ordinations. Environmental fitting (envfit function, 999 permutations) identified clinical variables significantly associated with viral community structure. Statistical significance was defined as p &lt; 0.05, with marginally significant results (0.05 &lt; p &lt; 0.10) noted where relevant.</p></sec><sec id="S17"><title>Data Visualisation</title><p id="P48">Figures were produced using ggplot2 in R<sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref></sup>. Genome maps were produced using LoVis4u<sup><xref ref-type="bibr" rid="R65">65</xref></sup>. Synteny comparisons were produced using Clinker<sup><xref ref-type="bibr" rid="R66">66</xref></sup>.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Tables</label><media xlink:href="EMS206962-supplement-Supplementary_Tables.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Materials</label><media xlink:href="EMS206962-supplement-Supplementary_Materials.pdf" mimetype="application" mime-subtype="pdf" id="d2aAcEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S18"><title>Acknowledgments</title><p>We gratefully acknowledge all authors of the original publication that produced this dataset. We also acknowledge the contributions of all patients and participants that contributed their samples, and the clinicians that are overseeing treatment of these patients. This work was supported by the NIHR Leicester Biomedical Research Centre and the NIHR Leicester Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.</p><p>R.A.C. and E.M.A. are funded through the Biotechnology and Biological Sciences Research Council (BBSRC) grant Bacteriophages in Gut Health BB/W015706/1. E.M.A. gratefully acknowledges the support of the BBSRC; this research was funded by the BBSRC Institute Strategic Programme Food Microbiome and Health BB/X011054/1 and its constituent projects BBS/E/F/000PR13631 and BBS/E/F/000PR13633; and by the BBSRC Institute Strategic Programme Microbes and Food Safety BB/X011011/1 and its constituent projects BBS/E/F/000PR13634, BBS/E/F/000PR13635 and BBS/E/F/000PR13636. A.M. was funded by MRC-CLIMB (MR/L015080/1) and CLIMB-BIG-DATA (MR/T030062/1), with bioinformatics analysis carried out on infrastructure provided by MRC-CLIMB and CLIMB-BIG-DATA. Y.Y., Z.L., F.W., R.C., and Z.W. would like to gratefully acknowledge National Key R&amp;D Program of China (2022YFA1304300 to Z.W.), National Natural Science Foundation of China (82495200, 82495201, 32170109 to Z.W.), Major Project of Guangzhou National Laboratory (GZNL2023A02001 to Z.W.), the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0528400 to Z.W.)</p></ack><sec id="S19" sec-type="data-availability"><title>Data Availability</title><p id="P49">No primary data was generated as part of this study. The vOTU catalogue and supplementary tables have been made available on Figshare at: <ext-link ext-link-type="uri" xlink:href="https://figshare.com/s/eb8f56f9cc1e0a2cbcdc">https://figshare.com/s/eb8f56f9cc1e0a2cbcdc</ext-link>.</p></sec><fn-group><fn fn-type="con" id="FN1"><p id="P50"><bold>Contributions</bold></p><p id="P51">R.A.C. and C.E.B. conceived the idea. Y.Y., Z.L., F.W., R.C. and Z.W. provided data and materials. R.A.C., A.J.P., A.T., M.R.J.C, A.D.M, and C.E.B. analysed the data. R.A.C. drafted the manuscript. R.A.C., A.J.P., A.T., Z.W., E.M.A., M.R.J.C, A.D.M, and C.E.B. edited the manuscript. All authors read and approved the final manuscript.</p></fn><fn id="FN2" fn-type="conflict"><p id="P52"><bold>Ethics Declarations</bold></p><p id="P53">The authors have no competing interests to declare. No additional ethics were required for this re-analysis of previously published data.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><article-title>Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015</article-title><source>Lancet</source><year>2016</year><volume>388</volume><fpage>1459</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)31012-1</pub-id><pub-id pub-id-type="pmcid">PMC5388903</pub-id><pub-id pub-id-type="pmid">27733281</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="web"><collab>(GOLD), GI. f. C. O. L. D</collab><source>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2025 report</source><year>2025</year><comment>&lt;<ext-link ext-link-type="uri" xlink:href="https://goldcopd.org/2025-gold-report/">https://goldcopd.org/2025-gold-report/</ext-link>&gt;</comment></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><etal/><name><surname>Zhou</surname><given-names>Y</given-names></name></person-group><article-title>Characteristics of inflammatory phenotypes in patients with chronic obstructive pulmonary disease: a cross-sectional study</article-title><source>BMJ Open Respir Res</source><year>2023</year><volume>10</volume><pub-id pub-id-type="doi">10.1136/bmjresp-2022-001454</pub-id><pub-id pub-id-type="pmcid">PMC10689359</pub-id><pub-id pub-id-type="pmid">38035712</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Maschera</surname><given-names>B</given-names></name><name><surname>Lea</surname><given-names>S</given-names></name><name><surname>Kolsum</surname><given-names>U</given-names></name><name><surname>Michalovich</surname><given-names>D</given-names></name><name><surname>Van Horn</surname><given-names>S</given-names></name><name><surname>Traini</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Hessel</surname><given-names>EM</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name></person-group><article-title>Airway host-microbiome interactions in chronic obstructive pulmonary disease</article-title><source>Respir Res</source><year>2019</year><volume>20</volume><fpage>113</fpage><pub-id pub-id-type="doi">10.1186/s12931-019-1085-z</pub-id><pub-id pub-id-type="pmcid">PMC6555748</pub-id><pub-id pub-id-type="pmid">31170986</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><etal/><name><surname>Gao</surname><given-names>Z</given-names></name></person-group><article-title>Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study</article-title><source>Scientific Reports</source><year>2023</year><volume>13</volume><elocation-id>5715</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-32901-0</pub-id><pub-id pub-id-type="pmcid">PMC10080507</pub-id><pub-id pub-id-type="pmid">37029178</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Bafadhel</surname><given-names>M</given-names></name><name><surname>Haldar</surname><given-names>K</given-names></name><name><surname>Spivak</surname><given-names>A</given-names></name><name><surname>Mayhew</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>BE</given-names></name><name><surname>Tal-Singer</surname><given-names>R</given-names></name><name><surname>Johnston</surname><given-names>SL</given-names></name><name><surname>Ramsheh</surname><given-names>MY</given-names></name><name><surname>Barer</surname><given-names>MR</given-names></name><etal/><name><surname>Brown</surname><given-names>JR</given-names></name></person-group><article-title>Lung microbiome dynamics in COPD exacerbations</article-title><source>European Respiratory Journal</source><year>2016</year><volume>47</volume><fpage>1082</fpage><lpage>1092</lpage><pub-id pub-id-type="pmid">26917613</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Rijn</surname><given-names>AL</given-names></name><name><surname>van Boheemen</surname><given-names>S</given-names></name><name><surname>Sidorov</surname><given-names>I</given-names></name><name><surname>Carbo</surname><given-names>EC</given-names></name><name><surname>Pappas</surname><given-names>N</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Feltkamp</surname><given-names>M</given-names></name><name><surname>Aanerud</surname><given-names>M</given-names></name><name><surname>Bakke</surname><given-names>P</given-names></name><name><surname>Claas</surname><given-names>ECJ</given-names></name><etal/><name><surname>de Vries</surname><given-names>JJC</given-names></name></person-group><article-title>The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><elocation-id>e0223952</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0223952</pub-id><pub-id pub-id-type="pmcid">PMC6812800</pub-id><pub-id pub-id-type="pmid">31647831</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogokhia</surname><given-names>L</given-names></name><name><surname>Buhrke</surname><given-names>K</given-names></name><name><surname>Bell</surname><given-names>R</given-names></name><name><surname>Hoffman</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>DG</given-names></name><name><surname>Hanke-Gogokhia</surname><given-names>C</given-names></name><name><surname>Ajami</surname><given-names>NJ</given-names></name><name><surname>Wong</surname><given-names>MC</given-names></name><name><surname>Ghazaryan</surname><given-names>A</given-names></name><name><surname>Valentine</surname><given-names>JF</given-names></name><etal/><name><surname>Round</surname><given-names>JL</given-names></name></person-group><article-title>Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis</article-title><source>Cell Host Microbe</source><year>2019</year><volume>25</volume><fpage>285</fpage><lpage>299</lpage><elocation-id>e288</elocation-id><pub-id pub-id-type="doi">10.1016/j.chom.2019.01.008</pub-id><pub-id pub-id-type="pmcid">PMC6885004</pub-id><pub-id pub-id-type="pmid">30763538</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweere</surname><given-names>JM</given-names></name><name><surname>Van Belleghem</surname><given-names>JD</given-names></name><name><surname>Ishak</surname><given-names>H</given-names></name><name><surname>Bach</surname><given-names>MS</given-names></name><name><surname>Popescu</surname><given-names>M</given-names></name><name><surname>Sunkari</surname><given-names>V</given-names></name><name><surname>Kaber</surname><given-names>G</given-names></name><name><surname>Manasherob</surname><given-names>R</given-names></name><name><surname>Suh</surname><given-names>GA</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><etal/><name><surname>Bollyky</surname><given-names>PL</given-names></name></person-group><article-title>Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection</article-title><source>Science</source><year>2019</year><volume>363</volume><pub-id pub-id-type="doi">10.1126/science.aat9691</pub-id><pub-id pub-id-type="pmcid">PMC6656896</pub-id><pub-id pub-id-type="pmid">30923196</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gembara</surname><given-names>K</given-names></name><name><surname>Dąbrowska</surname><given-names>K</given-names></name></person-group><article-title>Phage-specific antibodies</article-title><source>Curr Opin Biotechnol</source><year>2021</year><volume>68</volume><fpage>186</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">33388538</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rodriguez-Brito</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>LL</given-names></name><name><surname>Wegley</surname><given-names>L</given-names></name><name><surname>Furlan</surname><given-names>M</given-names></name><name><surname>Angly</surname><given-names>F</given-names></name><name><surname>Breitbart</surname><given-names>M</given-names></name><name><surname>Buchanan</surname><given-names>J</given-names></name><name><surname>Desnues</surname><given-names>C</given-names></name><name><surname>Dinsdale</surname><given-names>E</given-names></name><name><surname>Edwards</surname><given-names>R</given-names></name><etal/><name><surname>Rohwer</surname><given-names>F</given-names></name></person-group><source>The ISME Journal 2010 4:6</source><publisher-name>Nature Publishing Group</publisher-name><year>2010</year><volume>4</volume><fpage>739</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">20147985</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldor</surname><given-names>MK</given-names></name><name><surname>Mekalanos</surname><given-names>JJ</given-names></name></person-group><source>Science</source><year>1996</year></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Khalil</surname><given-names>RKS</given-names></name><name><surname>Skinner</surname><given-names>C</given-names></name><name><surname>Patfield</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>X</given-names></name></person-group><source>Pathogens and Disease</source><publisher-name>Pathog Dis</publisher-name><year>2016</year><volume>74</volume><pub-id pub-id-type="pmid">27109772</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutcliffe</surname><given-names>SG</given-names></name><name><surname>Shamash</surname><given-names>M</given-names></name><name><surname>Hynes</surname><given-names>AP</given-names></name><name><surname>Maurice</surname><given-names>CF</given-names></name></person-group><article-title>Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut</article-title><source>Viruses</source><year>2021</year><volume>13</volume><pub-id pub-id-type="doi">10.3390/v13030455</pub-id><pub-id pub-id-type="pmcid">PMC8000485</pub-id><pub-id pub-id-type="pmid">33799646</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrot</surname><given-names>C</given-names></name><name><surname>Petit</surname><given-names>M-A</given-names></name></person-group><article-title>Signals triggering prophage induction in the gut microbiota</article-title><source>Molecular Microbiology</source><year>2022</year><volume>118</volume><fpage>494</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1111/mmi.14983</pub-id><pub-id pub-id-type="pmcid">PMC9827884</pub-id><pub-id pub-id-type="pmid">36164818</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgener</surname><given-names>EB</given-names></name><name><surname>Sweere</surname><given-names>JM</given-names></name><name><surname>Bach</surname><given-names>MS</given-names></name><name><surname>Secor</surname><given-names>PR</given-names></name><name><surname>Haddock</surname><given-names>N</given-names></name><name><surname>Jennings</surname><given-names>LK</given-names></name><name><surname>Marvig</surname><given-names>RL</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name><name><surname>Rossi</surname><given-names>E</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><etal/><name><surname>Milla</surname><given-names>CE</given-names></name></person-group><article-title>Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis</article-title><source>Sci Transl Med</source><year>2019</year><volume>11</volume><pub-id pub-id-type="doi">10.1126/scitranslmed.aau9748</pub-id><pub-id pub-id-type="pmcid">PMC7021451</pub-id><pub-id pub-id-type="pmid">30996083</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgener</surname><given-names>EB</given-names></name><name><surname>Cai</surname><given-names>P</given-names></name><name><surname>Kratochvil</surname><given-names>MJ</given-names></name><name><surname>Rojas-Hernandez</surname><given-names>LS</given-names></name><name><surname>Joo</surname><given-names>NS</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Secor</surname><given-names>PR</given-names></name><name><surname>Heilshorn</surname><given-names>SC</given-names></name><name><surname>Spakowitz</surname><given-names>AJ</given-names></name><name><surname>Wine</surname><given-names>JJ</given-names></name><etal/><name><surname>Milla</surname><given-names>CE</given-names></name></person-group><article-title>The lysogenic filamentous Pseudomonas bacteriophage phage Pf slows mucociliary transport</article-title><source>PNAS Nexus</source><year>2024</year><pub-id pub-id-type="doi">10.1093/pnasnexus/pgae390</pub-id><pub-id pub-id-type="pmcid">PMC11412248</pub-id><pub-id pub-id-type="pmid">39301510</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yi</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Ecklu-Mensah</surname><given-names>G</given-names></name><name><surname>Buschmann</surname><given-names>MM</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><etal/><name><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions</article-title><source>Nature Microbiology</source><year>2022</year><volume>7</volume><fpage>1361</fpage><lpage>1375</lpage><pub-id pub-id-type="pmid">35995842</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguli</surname><given-names>S</given-names></name><name><surname>Zapata</surname><given-names>G</given-names></name><name><surname>Wallis</surname><given-names>T</given-names></name><name><surname>Reid</surname><given-names>C</given-names></name><name><surname>Boulnois</surname><given-names>G</given-names></name><name><surname>Vann</surname><given-names>WF</given-names></name><name><surname>Roberts</surname><given-names>IS</given-names></name></person-group><article-title>Molecular cloning and analysis of genes for sialic acid synthesis in Neisseria meningitidis group B and purification of the meningococcal CMP-NeuNAc synthetase enzyme</article-title><source>J Bacteriol</source><year>1994</year><volume>176</volume><fpage>4583</fpage><lpage>4589</lpage><pub-id pub-id-type="doi">10.1128/jb.176.15.4583-4589.1994</pub-id><pub-id pub-id-type="pmcid">PMC196278</pub-id><pub-id pub-id-type="pmid">8045888</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García</surname><given-names>E</given-names></name></person-group><article-title>Structure, Function, and Regulation of LytA: The N-Acetylmuramoyl-l-alanine Amidase Driving the “Suicidal Tendencies” of Streptococcus pneumoniae-A Review</article-title><source>Microorganisms</source><year>2025</year><volume>13</volume><pub-id pub-id-type="doi">10.3390/microorganisms13040827</pub-id><pub-id pub-id-type="pmcid">PMC12029793</pub-id><pub-id pub-id-type="pmid">40284663</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>S</given-names></name><name><surname>Bastin</surname><given-names>DA</given-names></name><name><surname>Verma</surname><given-names>NK</given-names></name></person-group><article-title>Functional analysis of the O antigen glucosylation gene cluster of Shigella flexneri bacteriophage SfX</article-title><source>Microbiology (Reading)</source><year>1999</year><volume>145</volume><issue>Pt 5</issue><fpage>1263</fpage><lpage>1273</lpage><pub-id pub-id-type="pmid">10376843</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavris</surname><given-names>M</given-names></name><name><surname>Manning</surname><given-names>PA</given-names></name><name><surname>Morona</surname><given-names>R</given-names></name></person-group><article-title>Mechanism of bacteriophage SfII-mediated serotype conversion in Shigella flexneri</article-title><source>Mol Microbiol</source><year>1997</year><volume>26</volume><fpage>939</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">9426131</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title>Gut virome-wide association analysis identifies cross-population viral signatures for inflammatory bowel disease</article-title><source>Microbiome</source><year>2024</year><volume>12</volume><fpage>130</fpage><pub-id pub-id-type="doi">10.1186/s40168-024-01832-x</pub-id><pub-id pub-id-type="pmcid">PMC11256409</pub-id><pub-id pub-id-type="pmid">39026313</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clooney</surname><given-names>AG</given-names></name><name><surname>Sutton</surname><given-names>TDS</given-names></name><name><surname>Shkoporov</surname><given-names>AN</given-names></name><name><surname>Holohan</surname><given-names>RK</given-names></name><name><surname>Daly</surname><given-names>KM</given-names></name><name><surname>O’Regan</surname><given-names>O</given-names></name><name><surname>Ryan</surname><given-names>FJ</given-names></name><name><surname>Draper</surname><given-names>LA</given-names></name><name><surname>Plevy</surname><given-names>SE</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><etal/><name><surname>Hill</surname><given-names>C</given-names></name></person-group><source>Cell Host &amp; Microbe</source><year>2019</year><volume>26</volume><fpage>764</fpage><lpage>778</lpage><elocation-id>e765</elocation-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monaco</surname><given-names>CL</given-names></name><name><surname>Gootenberg</surname><given-names>DB</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Handley</surname><given-names>SA</given-names></name><name><surname>Ghebremichael</surname><given-names>MS</given-names></name><name><surname>Lim</surname><given-names>ES</given-names></name><name><surname>Lankowski</surname><given-names>A</given-names></name><name><surname>Baldridge</surname><given-names>MT</given-names></name><name><surname>Wilen</surname><given-names>CB</given-names></name><name><surname>Flagg</surname><given-names>M</given-names></name><etal/><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group><article-title>Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome</article-title><source>Cell Host Microbe</source><year>2016</year><volume>19</volume><fpage>311</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.02.011</pub-id><pub-id pub-id-type="pmcid">PMC4821831</pub-id><pub-id pub-id-type="pmid">26962942</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregory</surname><given-names>AC</given-names></name><name><surname>Zablocki</surname><given-names>O</given-names></name><name><surname>Zayed</surname><given-names>AA</given-names></name><name><surname>Howell</surname><given-names>A</given-names></name><name><surname>Bolduc</surname><given-names>B</given-names></name><name><surname>Sullivan</surname><given-names>MB</given-names></name></person-group><article-title>The Gut Virome Database Reveals Age-Dependent Patterns of Virome Diversity in the Human Gut</article-title><source>Cell Host &amp; Microbe</source><year>2020</year><volume>28</volume><fpage>724</fpage><lpage>740</lpage><elocation-id>e728</elocation-id><pub-id pub-id-type="doi">10.1016/j.chom.2020.08.003</pub-id><pub-id pub-id-type="pmcid">PMC7443397</pub-id><pub-id pub-id-type="pmid">32841606</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camarillo-Guerrero</surname><given-names>LF</given-names></name><name><surname>Almeida</surname><given-names>A</given-names></name><name><surname>Rangel-Pineros</surname><given-names>G</given-names></name><name><surname>Finn</surname><given-names>RD</given-names></name><name><surname>Lawley</surname><given-names>TD</given-names></name></person-group><article-title>Massive expansion of human gut bacteriophage diversity</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>1098</fpage><lpage>1109</lpage><elocation-id>e1099</elocation-id><pub-id pub-id-type="doi">10.1016/j.cell.2021.01.029</pub-id><pub-id pub-id-type="pmcid">PMC7895897</pub-id><pub-id pub-id-type="pmid">33606979</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><article-title>fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><year>2018</year><volume>34</volume><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmcid">PMC6129281</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><article-title>Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM</article-title><source>arXiv</source><year>2013</year><elocation-id>1303.3997</elocation-id><comment>preprint arXiv</comment></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telatin</surname><given-names>A</given-names></name><name><surname>Fariselli</surname><given-names>P</given-names></name><name><surname>Birolo</surname><given-names>G</given-names></name></person-group><article-title>SeqFu: A Suite of Utilities for the Robust and Reproducible Manipulation of Sequence Files</article-title><source>Bioengineering</source><year>2021</year><volume>8</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.3390/bioengineering8050059</pub-id><pub-id pub-id-type="pmcid">PMC8148589</pub-id><pub-id pub-id-type="pmid">34066939</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nurk</surname><given-names>S</given-names></name><name><surname>Meleshko</surname><given-names>D</given-names></name><name><surname>Korobeynikov</surname><given-names>A</given-names></name><name><surname>Pevzner</surname><given-names>PA</given-names></name></person-group><source>Genome Research</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><year>2017</year><volume>27</volume><fpage>824</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1101/gr.213959.116</pub-id><pub-id pub-id-type="pmcid">PMC5411777</pub-id><pub-id pub-id-type="pmid">28298430</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijini</surname><given-names>M</given-names></name><name><surname>Michael</surname><given-names>JR</given-names></name><name><surname>Bhavya</surname><given-names>P</given-names></name><name><surname>Sarah</surname><given-names>KG</given-names></name><name><surname>Susanna</surname><given-names>RG</given-names></name><name><surname>Przemyslaw</surname><given-names>D</given-names></name><name><surname>George</surname><given-names>B</given-names></name><name><surname>Ryan</surname><given-names>DH</given-names></name><name><surname>Laura</surname><given-names>KI</given-names></name><name><surname>Abbey</surname><given-names>LKH</given-names></name><etal/><name><surname>Robert</surname><given-names>AE</given-names></name></person-group><article-title>Phables: from fragmented assemblies to high-quality bacteriophage genomes</article-title><source>bioRxiv</source><year>2023</year><elocation-id>2023.2004.2004.535632</elocation-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btad586</pub-id><pub-id pub-id-type="pmcid">PMC10563150</pub-id><pub-id pub-id-type="pmid">37738590</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>R</given-names></name><name><surname>Telatin</surname><given-names>A</given-names></name><name><surname>Hsieh</surname><given-names>SY</given-names></name><name><surname>Newberry</surname><given-names>F</given-names></name><name><surname>Tariq</surname><given-names>MA</given-names></name><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Carding</surname><given-names>SR</given-names></name><name><surname>Adriaenssens</surname><given-names>EM</given-names></name></person-group><article-title>Nanopore and Illumina sequencing reveal different viral populations from human gut samples</article-title><source>Microb Genom</source><year>2024</year><volume>10</volume><pub-id pub-id-type="doi">10.1099/mgen.0.001236</pub-id><pub-id pub-id-type="pmcid">PMC11092197</pub-id><pub-id pub-id-type="pmid">38683195</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camargo</surname><given-names>AP</given-names></name><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>F</given-names></name><name><surname>Babinski</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Chain</surname><given-names>PSG</given-names></name><name><surname>Nayfach</surname><given-names>S</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name></person-group><article-title>Identification of mobile genetic elements with geNomad</article-title><source>Nat Biotechnol</source><year>2023</year><pub-id pub-id-type="doi">10.1038/s41587-023-01953-y</pub-id><pub-id pub-id-type="pmcid">PMC11324519</pub-id><pub-id pub-id-type="pmid">37735266</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayfach</surname><given-names>S</given-names></name><name><surname>Camargo</surname><given-names>AP</given-names></name><name><surname>Schulz</surname><given-names>F</given-names></name><name><surname>Eloe-Fadrosh</surname><given-names>E</given-names></name><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name></person-group><article-title>CheckV assesses the quality and completeness of metagenome-assembled viral genomes</article-title><source>Nature Biotechnology</source><year>2021</year><volume>39</volume><fpage>578</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-00774-7</pub-id><pub-id pub-id-type="pmcid">PMC8116208</pub-id><pub-id pub-id-type="pmid">33349699</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><source>Journal of Molecular Biology</source><publisher-name>Academic Press</publisher-name><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Adriaenssens</surname><given-names>EM</given-names></name><name><surname>Dutilh</surname><given-names>BE</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name><name><surname>Kropinski</surname><given-names>AM</given-names></name><name><surname>Krupovic</surname><given-names>M</given-names></name><name><surname>Kuhn</surname><given-names>JH</given-names></name><name><surname>Lavigne</surname><given-names>R</given-names></name><name><surname>Brister</surname><given-names>JR</given-names></name><name><surname>Varsani</surname><given-names>A</given-names></name><etal/><name><surname>Eloe-Fadrosh</surname><given-names>E</given-names></name></person-group><source>Nature biotechnology</source><publisher-name>Nature Publishing Group US</publisher-name><year>2019</year><volume>37</volume><fpage>29</fpage><lpage>37</lpage></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>R</given-names></name><name><surname>Telatin</surname><given-names>A</given-names></name><name><surname>Bouras</surname><given-names>G</given-names></name><name><surname>Camargo</surname><given-names>AP</given-names></name><name><surname>Larralde</surname><given-names>M</given-names></name><name><surname>Edwards</surname><given-names>RA</given-names></name><name><surname>Adriaenssens</surname><given-names>EM</given-names></name></person-group><article-title>Driving through stop signs: predicting stop codon reassignment improves functional annotation of bacteriophages</article-title><source>ISME Communications</source><year>2024</year><volume>4</volume><pub-id pub-id-type="doi">10.1093/ismeco/ycae079</pub-id><pub-id pub-id-type="pmcid">PMC11210395</pub-id><pub-id pub-id-type="pmid">38939532</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouras</surname><given-names>G</given-names></name><name><surname>Nepal</surname><given-names>R</given-names></name><name><surname>Houtak</surname><given-names>G</given-names></name><name><surname>Psaltis</surname><given-names>AJ</given-names></name><name><surname>Wormald</surname><given-names>P-J</given-names></name><name><surname>Vreugde</surname><given-names>S</given-names></name></person-group><article-title>Pharokka: a fast scalable bacteriophage annotation tool</article-title><source>Bioinformatics</source><year>2022</year><volume>39</volume><pub-id pub-id-type="doi">10.1093/bioinformatics/btac776</pub-id><pub-id pub-id-type="pmcid">PMC9805569</pub-id><pub-id pub-id-type="pmid">36453861</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>PP</given-names></name><name><surname>Lowe</surname><given-names>TM</given-names></name></person-group><article-title>tRNAscan-SE: Searching for tRNA Genes in Genomic Sequences</article-title><source>Methods Mol Biol</source><year>2019</year><volume>1962</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9173-0_1</pub-id><pub-id pub-id-type="pmcid">PMC6768409</pub-id><pub-id pub-id-type="pmid">31020551</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laslett</surname><given-names>D</given-names></name><name><surname>Canback</surname><given-names>B</given-names></name></person-group><article-title>ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh152</pub-id><pub-id pub-id-type="pmcid">PMC373265</pub-id><pub-id pub-id-type="pmid">14704338</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bland</surname><given-names>C</given-names></name><name><surname>Ramsey</surname><given-names>TL</given-names></name><name><surname>Sabree</surname><given-names>F</given-names></name><name><surname>Lowe</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name><name><surname>Hugenholtz</surname><given-names>P</given-names></name></person-group><article-title>CRISPR Recognition Tool (CRT): a tool for automatic detection of clustered regularly interspaced palindromic repeats</article-title><source>BMC Bioinformatics</source><year>2007</year><volume>8</volume><fpage>209</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-8-209</pub-id><pub-id pub-id-type="pmcid">PMC1924867</pub-id><pub-id pub-id-type="pmid">17577412</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Terzian</surname><given-names>P</given-names></name><name><surname>Olo Ndela</surname><given-names>E</given-names></name><name><surname>Galiez</surname><given-names>C</given-names></name><name><surname>Lossouarn</surname><given-names>J</given-names></name><name><surname>Pérez Bucio</surname><given-names>RE</given-names></name><name><surname>Mom</surname><given-names>R</given-names></name><name><surname>Toussaint</surname><given-names>A</given-names></name><name><surname>Petit</surname><given-names>MA</given-names></name><name><surname>Enault</surname><given-names>F</given-names></name></person-group><source>NAR Genomics and Bioinformatics</source><publisher-name>Oxford Academic</publisher-name><year>2021</year><volume>3</volume></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>Q</given-names></name></person-group><article-title>VFDB: a reference database for bacterial virulence factors</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>D325</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1093/nar/gki008</pub-id><pub-id pub-id-type="pmcid">PMC539962</pub-id><pub-id pub-id-type="pmid">15608208</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alcock</surname><given-names>BP</given-names></name><name><surname>Raphenya</surname><given-names>AR</given-names></name><name><surname>Lau</surname><given-names>TTY</given-names></name><name><surname>Tsang</surname><given-names>KK</given-names></name><name><surname>Bouchard</surname><given-names>M</given-names></name><name><surname>Edalatmand</surname><given-names>A</given-names></name><name><surname>Huynh</surname><given-names>W</given-names></name><name><surname>Nguyen</surname><given-names>A-LV</given-names></name><name><surname>Cheng</surname><given-names>AA</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/><name><surname>McArthur</surname><given-names>AG</given-names></name></person-group><source>Nucleic acids research</source><publisher-name>Oxford University Press</publisher-name><year>2020</year><volume>48</volume><fpage>D517</fpage><lpage>D525</lpage></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name></person-group><article-title>MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets</article-title><source>Nature Biotechnology</source><year>2017</year><volume>35</volume><fpage>1026</fpage><lpage>1028</lpage><pub-id pub-id-type="pmid">29035372</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larralde</surname><given-names>M</given-names></name><name><surname>Zeller</surname><given-names>G</given-names></name></person-group><article-title>PyHMMER: a Python library binding to HMMER for efficient sequence analysis</article-title><source>Bioinformatics</source><year>2023</year><volume>39</volume><pub-id pub-id-type="doi">10.1093/bioinformatics/btad214</pub-id><pub-id pub-id-type="pmcid">PMC10159651</pub-id><pub-id pub-id-type="pmid">37074928</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>N</given-names></name><name><surname>Redgwell</surname><given-names>T</given-names></name><name><surname>Rihtman</surname><given-names>B</given-names></name><name><surname>Barnes</surname><given-names>M</given-names></name><name><surname>Clokie</surname><given-names>M</given-names></name><name><surname>Stekel</surname><given-names>DJ</given-names></name><name><surname>Hobman</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>MA</given-names></name><name><surname>Millard</surname><given-names>A</given-names></name></person-group><source>Phage</source><publisher-name>Cold Spring Harbor Laboratory</publisher-name><year>2021</year><volume>2</volume><fpage>214</fpage><lpage>223</lpage></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ondov</surname><given-names>BD</given-names></name><name><surname>Treangen</surname><given-names>TJ</given-names></name><name><surname>Melsted</surname><given-names>P</given-names></name><name><surname>Mallonee</surname><given-names>AB</given-names></name><name><surname>Bergman</surname><given-names>NH</given-names></name><name><surname>Koren</surname><given-names>S</given-names></name><name><surname>Phillippy</surname><given-names>AM</given-names></name></person-group><source>Genome Biology</source><publisher-name>BioMed Central Ltd</publisher-name><year>2016</year><volume>17</volume><fpage>132</fpage><pub-id pub-id-type="doi">10.1186/s13059-016-0997-x</pub-id><pub-id pub-id-type="pmcid">PMC4915045</pub-id><pub-id pub-id-type="pmid">27323842</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzinger</surname><given-names>M</given-names></name><name><surname>Weissenow</surname><given-names>K</given-names></name><name><surname>Joaquin</surname><given-names>G</given-names></name><name><surname>Henkel</surname><given-names>A</given-names></name><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Rost</surname><given-names>B</given-names></name></person-group><article-title>Bilingual language model for protein sequence and structure</article-title><source>NAR Genomics and Bioinformatics</source><year>2024</year><volume>6</volume><pub-id pub-id-type="doi">10.1093/nargab/lqae150</pub-id><pub-id pub-id-type="pmcid">PMC11616678</pub-id><pub-id pub-id-type="pmid">39633723</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kempen</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Tumescheit</surname><given-names>C</given-names></name><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Gilchrist</surname><given-names>CLM</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name></person-group><article-title>Fast and accurate protein structure search with Foldseek</article-title><source>Nature Biotechnology</source><year>2024</year><volume>42</volume><fpage>243</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1038/s41587-023-01773-0</pub-id><pub-id pub-id-type="pmcid">PMC10869269</pub-id><pub-id pub-id-type="pmid">37156916</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Camargo</surname><given-names>AP</given-names></name><name><surname>Coutinho</surname><given-names>FH</given-names></name><name><surname>Dabdoub</surname><given-names>SM</given-names></name><name><surname>Dutilh</surname><given-names>BE</given-names></name><name><surname>Nayfach</surname><given-names>S</given-names></name><name><surname>Tritt</surname><given-names>A</given-names></name></person-group><article-title>iPHoP: An integrated machine learning framework to maximize host prediction for metagenome-derived viruses of archaea and bacteria</article-title><source>PLOS Biology</source><year>2023</year><volume>21</volume><elocation-id>e3002083</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3002083</pub-id><pub-id pub-id-type="pmcid">PMC10155999</pub-id><pub-id pub-id-type="pmid">37083735</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>FH</given-names></name><name><surname>Zaragoza-Solas</surname><given-names>A</given-names></name><name><surname>López-Pérez</surname><given-names>M</given-names></name><name><surname>Barylski</surname><given-names>J</given-names></name><name><surname>Zielezinski</surname><given-names>A</given-names></name><name><surname>Dutilh</surname><given-names>BE</given-names></name><name><surname>Edwards</surname><given-names>R</given-names></name><name><surname>Rodriguez-Valera</surname><given-names>F</given-names></name></person-group><source>Patterns</source><publisher-name>Elsevier</publisher-name><year>2021</year><volume>2</volume><elocation-id>100274</elocation-id><pub-id pub-id-type="doi">10.1016/j.patter.2021.100274</pub-id><pub-id pub-id-type="pmcid">PMC8276007</pub-id><pub-id pub-id-type="pmid">34286299</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galiez</surname><given-names>C</given-names></name><name><surname>Siebert</surname><given-names>M</given-names></name><name><surname>Enault</surname><given-names>F</given-names></name><name><surname>Vincent</surname><given-names>J</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name></person-group><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>3113</fpage><lpage>3114</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx383</pub-id><pub-id pub-id-type="pmcid">PMC5870724</pub-id><pub-id pub-id-type="pmid">28957499</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ahlgren</surname><given-names>NA</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name><name><surname>Fuhrman</surname><given-names>JA</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name></person-group><source>Nucleic Acids Research</source><publisher-name>Oxford Academic</publisher-name><year>2017</year><volume>45</volume><fpage>39</fpage><lpage>53</lpage></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name></person-group><source>BMC Biology</source><year>2021</year><volume>19</volume><fpage>5</fpage></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name></person-group><article-title>PhaTYP: predicting the lifestyle for bacteriophages using BERT</article-title><source>Briefings in Bioinformatics</source><year>2022</year><volume>24</volume><pub-id pub-id-type="doi">10.1093/bib/bbac487</pub-id><pub-id pub-id-type="pmcid">PMC9851330</pub-id><pub-id pub-id-type="pmid">36659812</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millard</surname><given-names>A</given-names></name><name><surname>Denise</surname><given-names>R</given-names></name><name><surname>Lestido</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>MT</given-names></name><name><surname>Webster</surname><given-names>D</given-names></name><name><surname>Turner</surname><given-names>D</given-names></name><name><surname>Sicheritz-Pontén</surname><given-names>T</given-names></name></person-group><article-title>taxMyPhage: Automated Taxonomy of dsDNA Phage Genomes at the Genus and Species Level</article-title><source>PHAGE</source><volume>0</volume><comment>null</comment><pub-id pub-id-type="doi">10.1089/phage.2024.0050</pub-id><pub-id pub-id-type="pmcid">PMC12060842</pub-id><pub-id pub-id-type="pmid">40351403</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><source>Nature methods</source><publisher-name>NIH Public Access</publisher-name><year>2012</year><volume>9</volume><fpage>357</fpage></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Wysoker</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Marth</surname><given-names>G</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>Subgroup</surname><given-names>GPDP</given-names></name></person-group><source>Bioinformatics (Oxford, England)</source><publisher-name>Oxford University Press</publisher-name><year>2009</year><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>S</given-names></name><name><surname>Emerson</surname><given-names>JB</given-names></name><name><surname>Eloe-Fadrosh</surname><given-names>EA</given-names></name><name><surname>Sullivan</surname><given-names>MB</given-names></name></person-group><source>PeerJ</source><year>2017</year><volume>2017</volume><elocation-id>e3817</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.3817</pub-id><pub-id pub-id-type="pmcid">PMC5610896</pub-id><pub-id pub-id-type="pmid">28948103</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Míguez</surname><given-names>A</given-names></name><name><surname>Beghini</surname><given-names>F</given-names></name><name><surname>Cumbo</surname><given-names>F</given-names></name><name><surname>McIver</surname><given-names>LJ</given-names></name><name><surname>Thompson</surname><given-names>KN</given-names></name><name><surname>Zolfo</surname><given-names>M</given-names></name><name><surname>Manghi</surname><given-names>P</given-names></name><name><surname>Dubois</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>KD</given-names></name><name><surname>Thomas</surname><given-names>AM</given-names></name><etal/><name><surname>Segata</surname><given-names>N</given-names></name></person-group><article-title>Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4</article-title><source>Nature Biotechnology</source><year>2023</year><volume>41</volume><fpage>1633</fpage><lpage>1644</lpage><pub-id pub-id-type="doi">10.1038/s41587-023-01688-w</pub-id><pub-id pub-id-type="pmcid">PMC10635831</pub-id><pub-id pub-id-type="pmid">36823356</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><source>Ggplot2: Elegant graphics for data analysis</source><publisher-name>Springer International Publishing</publisher-name><year>2016</year><edition>2</edition></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="book"><collab>Team, RC</collab><source>R: A language and environment for statistical computing</source><publisher-name>R Foundation for Statistical Computing</publisher-name><year>2018</year></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egorov</surname><given-names>AA</given-names></name><name><surname>Atkinson</surname><given-names>GC</given-names></name></person-group><article-title>LoVis4u: a locus visualization tool for comparative genomics and coverage profiles</article-title><source>NAR Genom Bioinform</source><year>2025</year><volume>7</volume><elocation-id>lqaf009</elocation-id><pub-id pub-id-type="doi">10.1093/nargab/lqaf009</pub-id><pub-id pub-id-type="pmcid">PMC11850299</pub-id><pub-id pub-id-type="pmid">40007724</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname><given-names>CLM</given-names></name><name><surname>Chooi</surname><given-names>Y-H</given-names></name></person-group><article-title>clinker &amp;amp; clustermap.js: automatic generation of gene cluster comparison figures</article-title><source>Bioinformatics</source><year>2021</year><volume>37</volume><fpage>2473</fpage><lpage>2475</lpage><pub-id pub-id-type="pmid">33459763</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Overview of study cohort and viral catalogue characteristics.</title><p>(<bold>A</bold>) Distribution of samples across GOLD stages, including healthy controls (H) and GOLD stages 1-4. (<bold>B</bold>) Distribution of samples across ABE classification groups: Healthy, Group A (low symptoms/low exacerbations), Group B (high symptoms/low exacerbations), Group E (frequent exacerbations), and Unclassified. (<bold>C</bold>) Distribution of samples across inflammatory endotypes. (<bold>D</bold>) CheckV quality assessment of 1,308 viral operational taxonomic units (vOTUs) categorised as Complete, High-quality, Medium-quality, Low-quality, or Not-determined. (<bold>E</bold>) Length distribution of vOTUs displayed on a log10 scale with mean (red dashed line) and median (green dashed line) indicated. (<bold>F</bold>) Top 15 most frequently predicted viral families, coloured by realm classification. (<bold>G</bold>) Top 15 most frequently predicted bacterial host genera, coloured by phylum. (<bold>H</bold>) Predicted viral lifestyle, showing temperate, lytic, and unknown categories. Numbers above bars indicate number of samples or vOTUs for each category.</p></caption><graphic xlink:href="EMS206962-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Progressive viral diversity loss and ecological decoupling in COPD.</title><p>(<bold>A</bold>) Viral Shannon diversity across GOLD stages showing progressive decline with disease severity (n = 135; Kruskal-Wallis χ<sup>2</sup> = 16.99, df = 4, P = 0.002). (<bold>B</bold>) Viral Shannon diversity across ABE groups demonstrating reduced diversity in all COPD phenotypes compared to healthy controls (n = 135; Kruskal-Wallis χ<sup>2</sup> = 13.47, df = 4, P = 0.009). (<bold>C</bold>) Viral Shannon diversity by inflammatory endotype revealed significantly reduced diversity in eosinophilic (P = 0.017) and mixed granulocytic (P = 0.011) phenotypes compared to healthy controls (n = 130 with endotype data; Kruskal-Wallis χ<sup>2</sup> = 15.45, df = 5, P = 0.009). (<bold>D</bold>) Correlation between bacterial and viral Shannon diversity stratified by ABE group, demonstrating preserved ecological coupling in Groups A (ρ = 0.643, P &lt; 0.005) and B (ρ = 0.511, P &lt; 0.005) but complete decoupling in frequent exacerbators (Group E; ρ = 0.052, P = 0.833). For all box plots: centre line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; points, individual samples. Spearman correlation coefficients (ρ) and P values shown for each group. Shaded areas represent 95% confidence intervals for linear regression lines.</p></caption><graphic xlink:href="EMS206962-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Limited viral community structuring across COPD clinical phenotypes.</title><p>(<bold>A</bold>) Principal coordinates analysis (PCoA) of viral community composition based on Bray-Curtis dissimilarity, coloured by ABE classification. Ellipses represent 95% confidence intervals. (<bold>B</bold>) PCoA of viral communities coloured by GOLD stage. (<bold>C</bold>) Beta-dispersion analysis showing distances to group centroids for ABE classifications. Box plots show median and interquartile range; individual points represent samples. PERMANOVA and PERMDISP statistics are shown on respective panels. n = 36 healthy controls, n = 36 Group A, n = 28 Group B, n = 29 Group E for ABE classification; n = 36 healthy, n = 28 GOLD 1, n = 55 GOLD 2, n = 14 GOLD 3, n = 8 GOLD 4 for GOLD stages.</p></caption><graphic xlink:href="EMS206962-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Selective depletion of oral and anaerobic bacteria-associated phages in COPD.</title><p>(<bold>A</bold>) Volcano plot showing differential abundance of phages, grouped by predicted bacterial host between COPD patients (n=99) and healthy controls (n=36). Points represent individual bacterial genera, with size indicating mean viral abundance (log10 CPM) and colour indicating host category. Dashed lines indicate log2 fold change = ±0.5 and adjusted p = 0.05 thresholds. (<bold>B</bold>) Comparison of viral and bacterial depletion for oral and anaerobic genera. Bars show fold change (healthy/COPD) for viral abundance and corresponding bacterial host abundance. (<bold>C</bold>) Virus-host ratio (VHR) plotted against bacterial host abundance across all samples (n=111 with sufficient data), coloured by GOLD stage. Dashed line shows linear regression fit. Spearman correlation coefficient and p-value are indicated. Both axes are log10-scaled.</p></caption><graphic xlink:href="EMS206962-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>Acute viral events drive extreme viral loads in the respiratory microbiome.</title><p>(<bold>A</bold>) Viral load comparison between healthy controls and COPD patients (y axis in log scale). Box plots show median and interquartile range, with individual samples shown as points. Diamonds indicate extreme viral load cases (&gt;10%, dashed line). Statistical significance determined by Wilcoxon rank-sum test. (<bold>B</bold>) Relationship between viral load and Shannon diversity. Points are coloured by disease status, with extreme cases (&gt;10%) highlighted with coloured borders and labelled. Dashed line shows linear regression with 95% confidence interval. Spearman correlation coefficient and p-value shown. (<bold>C</bold>,<bold>D</bold>) Composition of extreme viral load samples. Stacked bar charts show relative abundance of vOTUs in five samples with &gt;10% viral load, coloured by (<bold>C</bold>) viral family or (<bold>D</bold>) predicted bacterial host genus. Each segment represents an individual vOTU with black borders separating vOTUs within the same colour category, with the asterisk indicating a dominant vOTU. (<bold>E</bold>,<bold>F</bold>) Synteny comparisons of dominant vOTUs from suspected viral infections. Clinker alignments show genomic organisation and similarity between (<bold>E</bold>) vOTU from patient K171 and Human mastadenovirus B (GenBank: MW767985), and (<bold>F</bold>) vOTU from patient K170 and a swan-associated picorna-like virus (GenBank: MW588149). ORFs are colour-coded by gene cluster, with grey lines indicating pairwise alignments between homologous sequences. Line intensity reflects percentage identity of aligned regions.</p></caption><graphic xlink:href="EMS206962-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Virulence factor-encoding phages associate with elevated pathogen abundance.</title><p>(<bold>A</bold>) Genome maps of two virulence factor-encoding vOTUs predicted to infect key COPD pathogens. Top: vOTU targeting <italic>Haemophilus influenzae</italic> carrying <italic>neuA</italic> (acylneuraminate cytidylyltransferase). Bottom: vOTU targeting <italic>Streptococcus pneumoniae</italic> carrying <italic>lytA</italic> (autolysin). Open reading frames (ORFs) are coloured by PHROG functional category. Scale bars indicate genome length in bases. (<bold>B</bold>) <italic>Haemophilus</italic> abundance in colonised patients with and without <italic>neuA</italic>-encoding phages. Box plots show median and interquartile range; individual samples shown as points coloured by disease status. Among 68 <italic>Haemophilus</italic>-positive samples, those harbouring virulence phages (n = 5) showed 82-fold higher median bacterial abundance compared to those without (n = 63). Statistical significance determined by Wilcoxon rank-sum test.</p></caption><graphic xlink:href="EMS206962-f006"/></fig></floats-group></article>